JEROME B ZELDIS
CIK 1433982 · Executive VP of Research & Dev · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.69M
Companies
8
Total Filings
77
Lifetime Open-Market Net
-$1.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTCT | Director | 22,500 | $75.14 | $1.69M | -$2.00M | 15 | 2026-01-06 |
| NXGLW | Director | 106,664 | $0.03 | $2.9K | $106.6K | 8 | 2025-06-27 |
| SNGX | Director | — | $0.43 | — | $0 | 4 | 2025-06-20 |
| NEXI | Executive VP of Research & Dev | 5,882 | $0.00 | $1 | $100.0K | 3 | 2022-04-07 |
| SOLIGENIX, INC. (SNGXW) Delisted | Director | 25,917 | $0.01 | $233 | $12.8K | 9 | 2021-09-24 |
| Streamex Corp. (BSGM) Delisted | Director | 107,944 | $6.35 | $685.4K | $10.5K | 5 | 2020-07-15 |
| SRNE | See Remarks | 10,000 | $0.00 | $5 | $51.5K | 4 | 2018-11-27 |
| Alliqua BioMedical, Inc. (ALQA) Delisted | Director | 786,750 | — | — | $240.7K | 8 | 2017-07-03 |
Recent Filings · Page 7 of 8
77 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-02 | PTCT | Grant (A) | — | $0 | EDGAR |
| 2014-09-04 | Alliqua BioMedical, Inc. (ALQA) Delisted | Exer (M) | +23,500 | $99.6K | EDGAR |
| 2014-08-01 | PTCT | Grant (A) | — | $0 | EDGAR |
| 2014-03-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-16 | — | Grant (A) | — | $0 | |
| 2013-10-01 | — | Grant (A) | — | $0 | |
| 2013-07-25 | — | Mixed | — | $0 | |
| 2013-07-02 | — | Mixed | +8,641,975 | $0 | |
| 2013-06-26 | — | Buy (P) | +23,809 | $25.0K | |
| 2013-06-24 | — | Exer (M) | +25,000 | $7.5K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.